Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-027582

Chief Executive Officer sold 13,000 shares at an average $83.04 ($1,079,501)

  • Chief Executive Officer acquired 13,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2018-05-01 Option exercise +13,000 $0.30 $3,933 13,000 D
Schenkein David P Chief Executive Officer 2018-05-01 Sale −10,086 $82.88 $835,928 2,914 D
Schenkein David P Chief Executive Officer 2018-05-01 Sale −2,814 $83.56 $235,138 100 D
Schenkein David P Chief Executive Officer 2018-05-01 Sale −100 $84.35 $8,435 0 D
Derivatives
Schenkein David P Chief Executive Officer 2018-05-01 Option exercise · Stock option (right to buy) −13,000 65,567 D
Open-market sales · 13,000 sh · avg $83.04 · $1,079,501
Loading xslF345X03/doc4.xml…